Pricing Log in Create free account
Friday 6 November 2026 Export RYTM’s income statement to Excel — free account

Rhythm Pharmaceuticals, Inc.

RYTM Healthcare Biotechnology

Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024.

Revenue
+79.6%
EPS
+26.9%
Free cash flow
+95.4%

Quarter to September 2026, against a year earlier

112.38 7.36 +7.01%
Market cap
$7.3B
P/E
0.0×
Fwd P/E
−31.6×
Dividend yield
—
F-score
6/9
Altman Z
15.89
Beneish M
−2.93
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Rhythm Pharmaceuticals, Inc. (RYTM) Book value per share

Alert me on Book value per share

Rhythm Pharmaceuticals, Inc.'s book value per share at the end of fiscal 2025 was 4.2×, up 54.0% from 2.7× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 2.9×. Over the past ten years it has ranged from 0.7× (fiscal 2016) to 10.9× (fiscal 2017); the current reading is higher than 55% of that period. Rhythm Pharmaceuticals, Inc. ranks 224th of 611 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 4.2× 54.03%
FY2024 2.7× (8.35%)
FY2023 2.9× (41.95%)
FY2022 5.1× (11.50%)
FY2021 5.7× 51.81%
FY2020 3.8× (51.09%)
FY2019 7.7× (2.86%)
FY2018 7.9× (27.22%)
FY2017 10.9× 1,424.75%
FY2016 0.7× (77.20%)

Quarterly newest first

Period Book value per share Change
Sep 2026 2.9× (7.86%)
Jun 2026 3.2× (9.37%)
Mar 2026 3.5× (15.87%)
Dec 2025 4.2× (6.88%)
37 more quarters

Against its own ten years

Low 0.7× High 10.9×
Ten-year median 4.2×
Current reading's percentile 55

Book value per share against peers

Company Book value per share
PRAX Praxis Precision Medicines, Inc. compare 46.0×
ORKA Oruka Therapeutics, Inc. compare 17.7×
CORT Corcept Therapeutics Incorporated compare 7.8×
ABVX Abivax SA Sponsored ADR compare 5.3×
ARWR Arrowhead Pharmaceuticals, Inc. compare 3.3×
RYTM Rhythm Pharmaceuticals, Inc. 2.9×
IONS Ionis Pharmaceuticals, Inc. compare 2.7×
AXSM Axsome Therapeutics, Inc. compare 2.0×
CYTK Cytokinetics, Incorporated compare 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on RYTM